Parkinson DiseaseNCT04835649
The Effectiveness of Telerehabilitation in Improving Upper Extremity in Parkinson's Patients
A study testing Exercise in people with Parkinson Disease, run by Gazi University at 1 site in Turkey (Türkiye).
Trial summary
Parkinson's Disease (PD) is a disease that affects the functional skills of the upper extremity with clinical findings such as bradykinesia, rigidity, and hypokinesia and causes limitations in the daily life activities of the patients. Read more about this study
- Who is it for?
- Ages 45 to 70 years
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Exercise
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Apr 2021to 25 May 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 45- 70 years of age
- Having diagnosed with "Parkinson's Disease" by a specialist physician
- Having between 1-3 stages according to the Hoehn and Yahr Scale
- Mini-Mental Test score more than or equal 24
Who cannot join
- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Ankara
About this study
Official title: The Effectiveness of Task-Oriented Training Based Telerehabilitation in Improving Upper Extremity Motor Function in Parkinson's Patients
Parkinson's Disease (PD) is a disease that affects the functional skills of the upper extremity with clinical findings such as bradykinesia, rigidity, and hypokinesia and causes limitations in the daily life activities of the patients. Task-oriented training (TOT) is a highly individualized, client-centered, occupational therapy, functional-based intervention compatible with motor learning and motor control principles such as intensive motor training, variable practice, and intermittent feedback. Few studies have been found on the TOT of the upper extremity in PD. Telerehabilitation of Parkinson's patients shows many strengths, such as cost-related and time-dependent ease, and the possibility of telecommunication with clinicians. In addition, the refinement of digital health solutions with the goal to offer a patient-tailored intervention remains an ongoing process. There are a limited number of studies on TOT and telerehabilitation of the upper extremity in PD. In addition, no studies have been found applying TOT through telerehabilitation. For this purpose, a study including TOT-based telerehabilitation in upper extremity education in PD was planned.
Read the detailed description
This study is a randomized controlled study. The patients will be randomly divided into two groups as exercise and control. Balance and walking exercises consisting of 3 days a week for 6 weeks will be given to both groups as a home program. In addition, the exercise group will receive TOT-based telerehabilitation via video conferencing 3 days a week for 6 weeks. TOT will be formed from daily life activities such as reaching out, grasping, writing, and manual skills, which are frequently used in daily life. As the outcome measures, disease severity and disability, finger and hand function, hand strength, and quality of life will be evaluated.
- Conditions
- Parkinson Disease
- Being tested
- Exercise
- Keywords
- Parkinson Disease, Telerehabilitation, Task-oriented, upper extremity
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseOther
Both groups will receive exercise-based training
| Study group | Role | What they receive |
|---|---|---|
| Exercise group | Experimental | The group that will receive task-oriented training via telerehabilitation Receives: Other: Exercise |
| Control group | Placebo comparator | The control group only will be given a home program that includes walking and balance exercises Receives: Other: Exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Manual dexterity performance - Baseline
Nine Hole Peg test (9-HPT)
Measured: Assessment will be conducted before the intervention
Manual dexterity performance - Post intervention
Nine Hole Peg test (9-HPT)
Measured: Assessment will be conducted immediately after the intervention
Finger and hand function - Baseline
Jebsen-Taylor Hand Function Test (JTHFT)
Measured: Assessment will be conducted before the intervention
Finger and hand function - Post intervention
Jebsen-Taylor Hand Function Test (JTHFT)
Measured: Assessment will be conducted immediately after the intervention
Upper extremity performance (coordination, dexterity and functioning) - Baseline
Action Research Arm Test (ARAT)
Measured: Assessment will be conducted before the intervention
Upper extremity performance (coordination, dexterity and functioning) - Post intervention
Action Research Arm Test (ARAT)
Measured: Assessment will be conducted immediately after the intervention
Secondary outcomes (8)
Isometric hand strength - Baseline
J-Tech ™
Measured: Assessment will be conducted before the intervention
Isometric hand strength - Post intervention
J-Tech ™
Measured: Assessment will be conducted immediately after the intervention
Isometric pinch strength - Baseline
Baseline® pinch meter
Measured: Assessment will be conducted before the intervention
Isometric pinch strength - Post intervention
Baseline® pinch meter
Measured: Assessment will be conducted immediately after the intervention
Disease severity and disability - Baseline
MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS has a maximum score of 272 and is composed of four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications) (UPDRS). (0= best , 272= worst)
Measured: Assessment will be conducted before the intervention
Disease severity and disability - Post intervention
MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UPDRS has a maximum score of 272 and is composed of four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications) (UPDRS). (0= best , 272= worst)
Measured: Assessment will be conducted immediately after the intervention
Health-related Quality of Life - Baseline
Parkinson's Disease Questionnaire 8 (PDQ-8). There are 8 questions in total and each question is scored from 0-4 points. High score indicates decreased quality of life
Measured: Assessment will be conducted before the intervention
Health-related Quality of Life - Post intervention
Parkinson's Disease Questionnaire 8 (PDQ-8). There are 8 questions in total and each question is scored from 0-4 points. High score indicates decreased quality of life
Measured: Assessment will be conducted immediately after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Apr 2021
- Study start15 Apr 2021
- Primary completion15 May 2022
- Study completion25 May 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by Gazi UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups as exercise group and control group
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gazi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sefa Eldemir, Gazi University
- Investigators
- Sefa Eldemir, PT, MSc., Study chair, Research AssistantArzu Güçlü-Gündüz, PT, PhD., Study director, Professor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04835649
- Sponsor's protocol ID
- 1- PD- UE-Telerehabilitation
- Status last verified
- May 2022
- First submitted
- 30 Mar 2021
- Last updated
- 27 May 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is not a plan to make IPD data but when the statistical analysis of all data is made, all results will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 27 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of Task-Oriented Training Based Telerehabilitation in Improving Upper Extremity Motor Function in Parkinson's Patients
- ClinicalTrials.gov ID
- NCT04835649
- Acronym / sponsor ID
- 1- PD- UE-Telerehabilitation
- Conditions
- Parkinson Disease
- Keywords
- Parkinson Disease, Telerehabilitation, Task-oriented, upper extremity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Gazi UniversityUniversity, hospital or other
- Study start
- 15 Apr 2021 (actual)
- Primary completion
- 15 May 2022 (actual)
- Study completion
- 25 May 2022 (actual)
- First posted
- 8 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Parkinson's Disease (PD) is a disease that affects the functional skills of the upper extremity with clinical findings such as bradykinesia, rigidity, and hypokinesia and causes limitations in the daily life activities of the patients. Task-oriented training (TOT) is a highly individualized, client-centered, occupational therapy, functional-based intervention compatible with motor learning and motor control principles such as intensive motor training, variable practice, and intermittent feedback. Few studies have been found on the TOT of the upper extremity in PD. Telerehabilitation of Parkinson's patients shows many strengths, such as cost-related and time-dependent ease, and the possibility of telecommunication with clinicians. In addition, the refinement of digital health solutions with the goal to offer a patient-tailored intervention remains an ongoing process. There are a limited number of studies on TOT and telerehabilitation of the upper extremity in PD. In addition, no studies have been found applying TOT through telerehabilitation. For this purpose, a study including TOT-based telerehabilitation in upper extremity education in PD was planned.
Detailed description
This study is a randomized controlled study. The patients will be randomly divided into two groups as exercise and control. Balance and walking exercises consisting of 3 days a week for 6 weeks will be given to both groups as a home program. In addition, the exercise group will receive TOT-based telerehabilitation via video conferencing 3 days a week for 6 weeks. TOT will be formed from daily life activities such as reaching out, grasping, writing, and manual skills, which are frequently used in daily life. As the outcome measures, disease severity and disability, finger and hand function, hand strength, and quality of life will be evaluated.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Two groups as exercise group and control group
| Arm | Type | Receives |
|---|---|---|
| Exercise group | Experimental | Other: ExerciseThe group that will receive task-oriented training via telerehabilitation |
| Control group | Placebo comparator | Other: ExerciseThe control group only will be given a home program that includes walking and balance exercises |
Who may qualify
- Ages
- 45 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- 45- 70 years of age
- Having diagnosed with "Parkinson's Disease" by a specialist physician
- Having between 1-3 stages according to the Hoehn and Yahr Scale
- Mini-Mental Test score more than or equal 24
Key exclusion criteria (1 listed)
- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExerciseBoth groups will receive exercise-based training | Other | Control group, Exercise group |
Primary outcome
Manual dexterity performance - Baseline
Time frame: Assessment will be conducted before the intervention
Nine Hole Peg test (9-HPT)
Manual dexterity performance - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Nine Hole Peg test (9-HPT)
Finger and hand function - Baseline
Time frame: Assessment will be conducted before the intervention
Jebsen-Taylor Hand Function Test (JTHFT)
Finger and hand function - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Jebsen-Taylor Hand Function Test (JTHFT)
Upper extremity performance (coordination, dexterity and functioning) - Baseline
Time frame: Assessment will be conducted before the intervention
Action Research Arm Test (ARAT)
Upper extremity performance (coordination, dexterity and functioning) - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Action Research Arm Test (ARAT)
8 secondary outcomes
Isometric hand strength - Baseline
Time frame: Assessment will be conducted before the intervention
Isometric hand strength - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Isometric pinch strength - Baseline
Time frame: Assessment will be conducted before the intervention
Isometric pinch strength - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Disease severity and disability - Baseline
Time frame: Assessment will be conducted before the intervention
Disease severity and disability - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Health-related Quality of Life - Baseline
Time frame: Assessment will be conducted before the intervention
Health-related Quality of Life - Post intervention
Time frame: Assessment will be conducted immediately after the intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 May 2022.
- Related infoLink provided by the sponsor.
- Related infoLink provided by the sponsor.
- Individual participant dataSharing planned: No. There is not a plan to make IPD data but when the statistical analysis of all data is made, all results will be shared.
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sefa Eldemir, PT, MSc. study chair
Research Assistant
Arzu Güçlü-Gündüz, PT, PhD. study director
Professor
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise in people with Parkinson Disease, run by Gazi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Manual dexterity performance - Baseline (time frame: Assessment will be conducted before the intervention). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2022.